Literature DB >> 16269935

Cross-laboratory audit of normal reference ranges and assessment of ABO blood group, gender and age on detected levels of plasma coagulation factors.

Emmanuel J Favaloro1, Soma Soltani, Jane McDonald, Ella Grezchnik, Leanne Easton.   

Abstract

We have assessed the influence of the ABO blood group, gender and age on plasma levels of the coagulation factors II, V, VII, VIII, IX, X, XI and XII as part of a quality audit of laboratory activities. There was no statistically significant difference in gender donor age (total normal donors: n = 406, mean/median age = 46.0/47.0 years, range = 16-77 years; females: n = 177, mean/median age = 44.7/46.0 years, range = 16-75 years; males: n = 229, mean/median age = 47.0/48.0 years, range = 17-77 years). With increasing age, we observed small but statistically significant rises (linear correlation; P < 0.01 for all parameters) in factors V, VII, VIII, IX and XI. With gender, we observed higher levels (P < 0.05) in females for factors II, VII, X, IX, XI and XII. With the ABO group, we observed lower levels in the O group (versus non-O group; P < 0.05) for factors VIII, IX and XII. We could therefore define differing normal reference ranges based on the differing study data. Study findings are compared with previously published literature, and this has identified a wide diversity in normal reference ranges both between different factors and between different studies. Finally, we also performed a cross-laboratory audit of peer laboratory practice and similarly show a wide diversity in normal reference ranges used between different laboratories.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16269935     DOI: 10.1097/01.mbc.0000187250.32630.56

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  7 in total

1.  Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma.

Authors:  Giancarlo Maria Liumbruno; Maria Laura Sodini; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2008-01       Impact factor: 3.443

2.  Personalized healthcare in clotting disorders.

Authors:  Haifeng M Wu; Lihui Xu; Daniel D Sedmak; Clay B Marsh; Mark W Wurster
Journal:  Per Med       Date:  2010-01       Impact factor: 2.512

Review 3.  Quality Assessment of Established and Emerging Blood Components for Transfusion.

Authors:  Jason P Acker; Denese C Marks; William P Sheffield
Journal:  J Blood Transfus       Date:  2016-12-14

4.  Factor X heterozygous mutation in a patient with potential risk of bleeding: A case report.

Authors:  Kotaro Arita; Hideki Niimi; Nana Yamagishi; Tomohiro Ueno; Isao Kitajima; Toshiro Sugiyama
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 5.  Pathophysiological Aspects of Aging in Venous Thromboembolism: An Update.

Authors:  Dimitra Akrivou; Garifallia Perlepe; Paraskevi Kirgou; Konstantinos I Gourgoulianis; Foteini Malli
Journal:  Medicina (Kaunas)       Date:  2022-08-10       Impact factor: 2.948

6.  Reference intervals for coagulation tests in adults with different ABO blood types.

Authors:  Zeliang Chen; Xiaoqing Dai; Jing Cao; Xuerui Tan; Shuying Chen; Min Yu
Journal:  J Clin Lab Anal       Date:  2022-02-04       Impact factor: 2.352

7.  Association of ABO and Colton Blood Group Gene Polymorphisms With Hematological Traits Variation.

Authors:  Shirin Shahbazi; Amir Mashayekhi; Neda Fatahi; Mohammad-Reza Mahdavi
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.